COVID and EBV aren’t always “one and done.” In susceptible people, they can rev up B cells that make autoantibodies, erode immune tolerance, and feed pathways seen in lupus, MS, and Long COVID. Reinfection isn’t harmless. Fewer infections = fewer chances to trigger that machinery.
Molecular Pathways Driving Autoantibody Production Following SARS-CoV-2 Infection Identified
Findings suggest that SARS-CoV-2 infection can activate an immune program that closely resembles those involved in established autoimmune disorders.
genengnews.com